Although CDK4/6 inhibitors sensitized A549 lung cancer cells to death induced by the anticancer drugs, WP631 and etoposide, in vitro, the idea of combining PARP1 repression should be considered on a case by case basis and particular attention should be paid to the type of cancer and death-inducing agents. Here, CDK4 is linked to lung carcinoma.